Our findings also nicely fit with other studies indicating that TCR binding affinity/avidity controls the functional profile of cancer-specific CD8 T-cells (29) and defines the optimal balance between effective antitumoral activity and autoimmunity (30). This evidence concerns the gene CD8A and Autoimmunity.